Privigen

BIOLOGICAL3 trials

Sponsors

Inova Health Care Services, Georgetown University, Institute for Clinical and Experimental Medicine

Conditions

Diffuse SclerodermaIschemic StrokeKidney TransplantationSystemic Sclerosis

Phase 1

IVIG in Acute Ischemic Stroke: A Pilot Study

WithdrawnNCT01628055

Inova Health Care ServicesIschemic Stroke

Start: 2013-03-31End: 2013-09-30Updated: 2013-11-11

Phase 3

rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

CompletedNCT04302805

Institute for Clinical and Experimental MedicineKidney Transplantation

Start: 2020-07-27End: 2024-06-15Updated: 2024-08-15

Unknown Phase

IVIG Treatment in Systemic Sclerosis

Georgetown UniversityDiffuse Scleroderma, Systemic Sclerosis

Start: 2013-04-30End: 2019-01-31Updated: 2018-07-17

Related Papers

12-Month Outcomes of a Prospective Randomized Trial Investigating Effects of IVIG on Top of rATG Versus rATG Alone in Pre-Sensitized Kidney Transplant Recipients: The INHIBIT Study

Transplant International2025-05-19